Metformin plus low-dose glimeperide significantly improves homeostasis model assessment for insulin resistance (HOMA<inf>IR</inf>) and β-cell function (HOMA<inf>β-cell</inf>) without hyperinsulinemia in patients with type 2 diabetes mellitus

Conference Object

Abstract: OBJECTIVE: Type 2 diabetes mellitus is characterized by insulin resistance and defects in insulin se

Palabras claves:

Glimeperide, HOMA, Homeostasis model assessment, Insulin Resistance, Metformin, Type 2 Diabetes mellitus, β-cell function

Autores:

Bermúdez-Arias F., Cano R.A., Cano-Ponce C., Ciscek A., Contreras F., Hernández-Hernandez R., Israili Z.H., Leal E.M., Lemus M.A., Medina M.T., Seyfi H.A., Souki-Rincón A., Valasco M., Valmore Bermúdez

Fuentes:

scopus